ArticleTherapeutic advances in neurological disorders2023

Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.

Marco Puthenparampil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.